Skadden and Drew & Napier advised Pfizer Inc. on the offering, while Simpson Thacher & Bartlett and Linklaters Singapore advised the underwriters. Pfizer Inc. (“Pfizer”) announced...
Pfizer’s $31 Billion Debt Offering
Pfizer’s Acquisition of Seagen
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
Anokion’s $35 Million Equity Funding from Pfizer
Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer. Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune...
Pfizer’s Acquisition of Global Blood Therapeutics
Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...
Bristol-Myers Squibb and Pfizer v. Sandoz and Pharmascience Canada Ltd.
McCarthy Tétrault is acting for Bristol-Myers Squibb and Pfizer. On January 12, 2021, Justice Zinn of Canada’s Federal Court released a decision in PM(NOC) litigation between...
Pfizer’s Minority Stake Investment in Valneva
Hogan Lovells has advised Valneva on the deal. Skadden advised Pfizer. Valneva signed a share subscription agreement by Pfizer in connection with the amendment of the...
GSK and Pfizer’s Demerger of Haleon
Wachtell, Lipton, Rosen & Katz and Clifford Chance served as Pfizer’s legal advisors, and Skadden, Arps, Slate, Meagher & Flom served as its tax advisor for...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Pfizer’s $525 Million Acquisition of ReViral
Goodwin advised ReViral on the deal. Clifford Chance advised Pfizer. ReViral announced its acquisition by Pfizer. Pfizer will acquire ReViral for a total consideration of up to...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
Pfizer’s Collaboration With Biohaven Pharmaceutical Company
Ropes & Gray represented Pfizer in the deal. Pfizer announced its collaboration arrangement with Biohaven Pharmaceutical Company to commercialize rimegepant, a therapy approved in the U.S. as...
Altaris Capital Partners’ Acquisition of Meridian Medical Technologies
Wachtell, Lipton, Rosen & Katz represented Pfizer in the transaction. Pfizer Inc. (NYSE: PFE) has entered into an agreement with Altaris Capital Partners, LLC, a healthcare...